Intrinsic Value
Lyra Therapeutics, Inc. (LYRA)
$4.03
-0.60 (-12.96%)
Enterprise Value | - |
---|---|
Net Debt | 4.53 |
Equity Value | - |
Shares Outstanding | 49.80 |
Equity Value Per Share | - |
Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt